Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Patients with the following characteristics often see the strongest improvements: Rheumatoid arthritis Psoriatic arthritis Osteoarthritis of the knees or hips Obesity or insulin resistance Chronic fatigue Long-term steroid use Difficulty losing weight despite trying Who Should Avoid GLP-1
We are unaware of any new NICE guidelines relating to this
The liquid format is ready to consume and ideal for use on the go or during active phases in everyday life and sports
Wegovy is available as a higher strength, 2.4 mg once weekly, which may be more effective for weight loss
[5] Treatment is lifelong
The global GLP-1 weight loss drug market was valued at $13.84 billion in 2024 and is projected to reach $48.84 billion by 2030, according to Grand View Research
US$ 27.31
US$ 25.27
.png)
US$ 25.06
US$ 24.97
US$ 22.89
US$ 23.33
US$ 27.96
US$ 29.15
